International Journal of Cancer Management

Published by: Kowsar
Crossmark

Factors Affecting Recurrence and Costs of Basal Cell Carcinoma Undergoing Mohs Micrographic Surgery: A Hospital-Based Retrospective Cohort Study

Leila Nassiripour ORCID 1 , Mohammadreza Amirsadri 2 , Maryam Tabatabaeian 3 and Mohammad Reza Maracy ORCID 1 , *
Authors Information
1 Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
3 Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • International Journal of Cancer Management: August 31, 2019, 12 (8); e84695
  • Published Online: August 7, 2019
  • Article Type: Research Article
  • Received: September 28, 2018
  • Revised: July 13, 2019
  • Accepted: July 16, 2019
  • DOI: 10.5812/ijcm.84695

How to Cite: Nassiripour L, Amirsadri M, Tabatabaeian M, Maracy M R. Factors Affecting Recurrence and Costs of Basal Cell Carcinoma Undergoing Mohs Micrographic Surgery: A Hospital-Based Retrospective Cohort Study, Int J Cancer Manag. 2019 ; 12(8):e84695. doi: 10.5812/ijcm.84695.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149(6):1200-6. doi: 10.1111/j.1365-2133.2003.05554.x. [PubMed: 14674897].
  • 2. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283-7. doi: 10.1001/archdermatol.2010.19. [PubMed: 20231499].
  • 3. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5. J Am Acad Dermatol. 1996;35(6):1012-3. doi: 10.1016/s0190-9622(96)90139-5. [PubMed: 8959974].
  • 4. American Cancer Society. Cancer Facts & Figures. 2011. Available from: http://www.cancer.org/research/cancerfactsfigures/CancerFactsFigures/cancer-facts-figures-2011.
  • 5. Nabizadeh R, Salehi S, Younesian M, Naddafi K. [Evaluation of the relationship between global ultraviolet indea in different regions of iran with skin cancer in 1383]. Iran J Health Environ. 2010;2(4):258-67. Persian.
  • 6. Jadotte YT, Sarkissian NA, Kadire H, Lambert WC. CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge. Eplasty. 2010;10. e46. [PubMed: 20596236]. [PubMed Central: PMC2890390].
  • 7. Abide JM, Nahai F, Bennett RG. The meaning of surgical margins. Plast Reconstr Surg. 1984;73(3):492-7. doi: 10.1097/00006534-198403000-00030. [PubMed: 6701225].
  • 8. Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: Tissue-sparing outcome. Dermatol Surg. 2009;35(9):1349-54. doi: 10.1111/j.1524-4725.2009.01240.x. [PubMed: 19500127].
  • 9. Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH, et al. Cost-effectiveness of mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol. 2006;142(2):187-94. doi: 10.1001/archderm.142.2.187. [PubMed: 16490846].
  • 10. Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008;9(12):1149-56. doi: 10.1016/S1470-2045(08)70260-2. [PubMed: 19010733].
  • 11. van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50(17):3011-20. doi: 10.1016/j.ejca.2014.08.018. [PubMed: 25262378].
  • 12. Wennberg AM, Larko O, Stenquist B. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol. 1999;79(5):370-2. doi: 10.1080/000155599750010292. [PubMed: 10494714].
  • 13. Paoli J, Daryoni S, Wennberg AM, Molne L, Gillstedt M, Miocic M, et al. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm Venereol. 2011;91(6):689-93. doi: 10.2340/00015555-1134. [PubMed: 21681360].
  • 14. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol. 2005;53(3):452-7. doi: 10.1016/j.jaad.2005.04.087. [PubMed: 16112352].
  • 15. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. Br J Dermatol. 2004;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x. [PubMed: 15270883].
  • 16. Veronese F, Farinelli P, Zavattaro E, Zuccoli R, Bonvini D, Leigheb G, et al. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol. 2012;26(7):838-43. doi: 10.1111/j.1468-3083.2011.04165.x. [PubMed: 21707774].
  • 17. Rowe DE, Carroll RJ, CL Jr CJ. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424-31. doi: 10.1111/j.1524-4725.1989.tb03249.x. [PubMed: 2925988].
  • 18. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315-28. doi: 10.1111/j.1524-4725.1989.tb03166.x. [PubMed: 2646336].
  • 19. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53(3):445-51. doi: 10.1016/j.jaad.2005.04.083. [PubMed: 16112351].
  • 20. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41-7. doi: 10.1046/j.1365-2133.2002.04804.x. [PubMed: 12100183].
  • 21. McGovern TW, Leffell DJ. Mohs surgery: The informed view. Arch Dermatol. 1999;135(10):1255-9. doi: 10.1001/archderm.135.10.1255. [PubMed: 10522675].
  • 22. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999;135(10):1177-83. doi: 10.1001/archderm.135.10.1177. [PubMed: 10522664].
  • 23. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol. 1992;18(6):471-6. doi: 10.1111/j.1524-4725.1992.tb03307.x. [PubMed: 1592998].
  • 24. Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: Randomised controlled trial. Lancet. 2004;364(9447):1766-72. doi: 10.1016/S0140-6736(04)17399-6. [PubMed: 15541449].
  • 25. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol. 1998;39(5 Pt 1):698-703. doi: 10.1016/s0190-9622(98)70041-6. [PubMed: 9810885].
  • 26. Bialy TL, Whalen J, Veledar E, Lafreniere D, Spiro J, Chartier T, et al. Mohs micrographic surgery vs traditional surgical excision: A cost comparison analysis. Arch Dermatol. 2004;140(6):736-42. doi: 10.1001/archderm.140.6.736. [PubMed: 15210467].
  • 27. Seidler AM, Bramlette TB, Washington CV, Szeto H, Chen SC. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: An analysis of cost-effectiveness. Dermatol Surg. 2009;35(11):1776-87. doi: 10.1111/j.1524-4725.2009.01291.x. [PubMed: 19737291].
  • 28. Ravitskiy L, Brodland DG, Zitelli JA. Cost analysis: Mohs micrographic surgery. Dermatol Surg. 2012;38(4):585-94. doi: 10.1111/j.1524-4725.2012.02341.x. [PubMed: 22443180].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments